Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
17.23
-0.32 (-1.82%)
At close: Jun 26, 2026, 4:00 PM EDT
17.27
+0.04 (0.23%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Aurinia Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Aurinia Pharmaceuticals stock have an average target of 16, with a low estimate of 15 and a high estimate of 17. The average target predicts a decrease of -7.14% from the current stock price of 17.23.
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Aurinia Pharmaceuticals stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bloom Burton | Bloom Burton | Hold Maintains $15 | Hold | Maintains | $15 | -12.94% | May 11, 2026 |
| RBC Capital | RBC Capital | Hold Reiterates $15 | Hold | Reiterates | $15 | -12.94% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $17 | Buy | Maintains | $17 | -1.33% | May 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | -1.33% | Feb 27, 2026 |
Financial Forecast
Revenue This Year
324.39M
from 283.06M
Increased by 14.60%
Revenue Next Year
386.92M
from 324.39M
Increased by 19.28%
EPS This Year
0.96
from 2.07
Decreased by -53.62%
EPS Next Year
1.12
from 0.96
Increased by 16.46%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 343.0M | 457.4M | |
| Avg | 324.4M | 386.9M | |
| Low | 310.0M | 360.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.2% | 41.0% | |
| Avg | 14.6% | 19.3% | |
| Low | 9.5% | 11.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 0.96 | 1.12 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -53.6% | 16.5% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.